Stage 3 CKD Underdiagnosed Globally
Approximately 2 in 5 adults with stage3 or higher CKD in the United States do not know they have it.
Diagnosis & Disease Information
Any Dipstick Proteinuria Predicts Worse Kidney Transplant Outcomes
Investigators reported findings from a case-control study of 438 recipients of living-donor kidneys.
Metformin for De Novo Diabetes in Kidney Transplant Recipients Cardioprotective
Investigators report a significantly lower risk for percutaneous coronary intervention.
Letermovir Approved for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
Letermovir appears to be better tolerated than the current standard of care, valganciclovir, a prodrug of ganciclovir, which frequently causes myelosuppression.
ESKD, Death Risks Are High After Heart Transplantation With Kidney Dysfunction
Severe renal dysfunction and short-term dialysis are common before heart-alone transplantation, a study found.
Aldosterone-Secreting Adrenal Adenomas Underdiagnosed in ESKD
Current screening guidelines may not capture all cases of hyperaldosteronism among patients with ESKD.
CVD, Diabetes Ups Hospitalization Risk for Living Kidney Donors
Hospitalization of living kidney donors may be “a sentinel event” for adverse outcomes.
Living Kidney Donation Barriers, Facilitators Identified
An online public opinion survey of US adults uncovers widespread concern about the health effects of donating a kidney and associated medical expenses.
KDPI Race Variable Found to Up Black Donor Kidney Discard Rate
Removing the race coefficient from the KDPI may increase use of Black deceased donor kidneys, according to investigators.
Low-Dose mTOR Inhibitor Combo Safe in De Novo Kidney Transplant Recipients
Findings from a prospective, randomized trial indicate that wound healing problems observed in early studies of high exposure to mTOR inhibitors can be prevented by using a dual regimen of everolimus and tacrolimus in low doses.
- Loading...
Loading...
Next post in American Transplant Congress
Loading... 
Loading...